Meghmani Organics Announces 7th AGM on Sep 8, 2026; Annual Report 2025-26 Released
Meghmani Organics Limited (MOL) will hold its 7th AGM on September 8, 2026. The company released its FY26 Annual Report, showing standalone revenue of ₹2,091.8 crore and PAT of ₹125.3 crore. Consolidated PAT turned positive at ₹28.7 crore. Remote e-voting is open from Sep 4-7, 2026.
The announcement is important for shareholders as it informs them about the AGM, voting procedures, and provides the Annual Report detailing the company's financial performance and future outlook. This information is crucial for investor decision-making.
The announcement is primarily a notice regarding the AGM and the release of the Annual Report. While the report details financial performance and strategic initiatives, the announcement itself is procedural and informational, lacking significant positive or negative catalysts.
Meghmani Organics Limited (MOL) has announced its 7th Annual General Meeting (AGM) will be held on Tuesday, 8th September, 2026, at 11:00 a.m. IST via Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The company has also released its Annual Report for the Financial Year 2025-26. This report includes audited standalone and consolidated financial statements, the Board of Directors' report, and the Statutory Auditors' report for the fiscal year.
In compliance with SEBI Listing Regulations, a letter containing a web-link to the Annual Report and the AGM Notice will be sent to shareholders whose email addresses are not registered. The remote e-voting period will commence on Friday, 4th September, 2026, at 9:00 a.m. IST and conclude on Monday, 7th September, 2026, at 5:00 p.m. IST. Shareholders eligible to vote as of the cut-off date, Tuesday, 1st September, 2026, can cast their votes remotely.
The Annual Report is also available on the company's website, www.meghmani.com. The report highlights the company's performance, strategic priorities, and commitment to sustainable agriculture and food security. It details the company's financial performance for FY26, including standalone revenue of ₹2,091.8 crore and Profit After Tax (PAT) of ₹125.3 crore, and consolidated PAT of ₹28.7 crore. Key initiatives include the establishment of a subsidiary in Brazil and approvals for nano-fertilizer production.
The company also reported a reduction in debt by approximately ₹160 crore, bringing the consolidated debt-to-equity ratio to 0.47x. A Scheme of Amalgamation for wholly owned subsidiaries Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited with Meghmani Organics Limited is underway to enhance operational efficiencies and simplify the group structure.
What to do with a filing like this
Meghmani Organics Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Meghmani Organics Limited. Read the original for the full detail.